General description
Midazolam is a benzodiazepine with a wide range of effects including anxiolytic, sedative, muscle relaxant, antiepileptic and anterograde amnesic.
INN
Midazolam
ATC codes
Medicine type
Chemical agent
EML status history
First added in 2009
(TRS
958)
for
Palliative care
Added in 2011
(TRS
965)
for
Sedative-hypnotic and anxiolytic drugs
Added in 2015
(TRS
994)
for
Status epilepticus
Changed in 2021
(TRS
1035)
for
Status epilepticus
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Preoperative medication and sedation for short-term procedures
- Parenteral > General injections > IV: 1 mg per mL
- Oral > Liquid: 2 mg per mL
- Oral > Solid > dosage form: 15 mg; 7.5 mg
Indications
Section
Medicines for other common symptoms in palliative care
- Oral > Liquid: 2 mg per mL
- Parenteral > General injections > unspecified: 1 mg per mL; 5 mg per mL
- Oral > Solid > dosage form: 7.5 mg; 15 mg
Indications
Section
Antiseizure medicines
- Parenteral > General injections > unspecified: 1 mg per mL in 5 mL vial (for buccal administration); 5 mg per mL in 1 mL vial (for buccal administration); 5 mg per mL in 3 mL vial (for buccal administration)
- Local > Buccal > Solution: 5 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 2 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.25 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.75 mL pre-filled syringe; 10 mg per mL in 1 mL pre-filled syringe (for oromucosal administration)
Indications